BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 11283727)

  • 1. Cbl: many adaptations to regulate protein tyrosine kinases.
    Thien CB; Langdon WY
    Nat Rev Mol Cell Biol; 2001 Apr; 2(4):294-307. PubMed ID: 11283727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
    Thien CB; Langdon WY
    Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system.
    Rao N; Dodge I; Band H
    J Leukoc Biol; 2002 May; 71(5):753-63. PubMed ID: 11994499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.
    Levkowitz G; Waterman H; Zamir E; Kam Z; Oved S; Langdon WY; Beguinot L; Geiger B; Yarden Y
    Genes Dev; 1998 Dec; 12(23):3663-74. PubMed ID: 9851973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Cbl: a regulator of T cell receptor-mediated signalling.
    Thien CB; Langdon WY
    Immunol Cell Biol; 1998 Oct; 76(5):473-82. PubMed ID: 9797470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.
    Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY
    Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes.
    Thien CB; Bowtell DD; Langdon WY
    J Immunol; 1999 Jun; 162(12):7133-9. PubMed ID: 10358158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase.
    Thien CB; Scaife RM; Papadimitriou JM; Murphy MA; Bowtell DD; Langdon WY
    J Exp Med; 2003 Feb; 197(4):503-13. PubMed ID: 12591907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement.
    Caveggion E; Continolo S; Pixley FJ; Stanley ER; Bowtell DD; Lowell CA; Berton G
    J Cell Physiol; 2003 May; 195(2):276-89. PubMed ID: 12652654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cbl family of signal transduction molecules.
    Smit L; Borst J
    Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration.
    Meng F; Lowell CA
    EMBO J; 1998 Aug; 17(15):4391-403. PubMed ID: 9687507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
    Bisson SA; Ujack EE; Robbins SM
    Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases.
    Peschard P; Park M
    Cancer Cell; 2003 Jun; 3(6):519-23. PubMed ID: 12842080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling.
    Ueno H; Sasaki K; Miyagawa K; Honda H; Mitani K; Yazaki Y; Hirai H
    J Biol Chem; 1997 Mar; 272(13):8739-43. PubMed ID: 9079708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases.
    Sanjay A; Horne WC; Baron R
    Sci STKE; 2001 Nov; 2001(110):pe40. PubMed ID: 11724969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of PTK signalling by Cbl proteins.
    Thien CB; Langdon WY
    Growth Factors; 2005 Jun; 23(2):161-7. PubMed ID: 16019438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cbl oncogene: a novel substrate of protein tyrosine kinases.
    Langdon WY
    Aust N Z J Med; 1995 Dec; 25(6):859-64. PubMed ID: 8770364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.